$AIXN
AiXin Life International, Inc. Stock $aixn

$aixn Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032179 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$1.196M	$672.8K	$702.4K
YoY Change	70.3%	-17.24%	3.76%
Cost Of Revenue	$1.015M	$619.7K	$668.2K
YoY Change	51.93%	37.33%	324.77%
Gross Profit	$181.1K	$53.08K	$34.24K
YoY Change	428.77%	-85.32%	-93.41%
Gross Profit Margin	15.14%	7.89%	4.87%
Selling, General & Admin	$705.2K	$426.5K	$658.3K
YoY Change	7.12%	-6.31%	74.6%
% of Gross Profit	389.51%	803.43%	1922.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$102.7K	$25.70K	$74.20K
YoY Change	38.34%	132.79%	734.65%
% of Gross Profit	56.7%	48.42%	216.71%
Operating Expenses	$705.2K	$1.207M	$658.3K
YoY Change	7.12%	165.1%	74.6%
Operating Profit	-$524.2K	-$533.9K	-$624.1K
YoY Change	-16.01%	470.96%	-537.75%
Interest Expense	$1.240K	$1.020K	$1.030K
YoY Change	20.39%	70.0%	-87.17%
% of Operating Profit
Other Income/Expense, Net	$7.990K	-$3.840M	$15.73K
YoY Change	-49.21%	-18472.87%	5950.0%
Pretax Income	-$514.9K	-$4.374M	-$607.3K
YoY Change	-15.22%	5973.92%	-502.59%
Income Tax	$450.00	-$322.00	-$17.83K
% Of Pretax Income
Net Earnings	-$515.4K	-$4.374M	-$589.5K
YoY Change	-12.58%	2893.51%	215.34%
Net Earnings / Revenue	-43.08%	-650.06%	-83.93%
Basic Earnings Per Share		-$0.09
Diluted Earnings Per Share	-$0.02	-$87.47K	-$11.79K
COMMON SHARES
Basic Shares Outstanding	50.00M shares	50.00M shares
Diluted Shares Outstanding		25.00M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$510.1K	$5.299M	$8.557M
YoY Change	-94.04%	60.67%	11.46%
Cash & Equivalents	$510.1K	$5.299M	$8.557M
Short-Term Investments
Other Short-Term Assets	$213.7K	$295.1K	$63.27K
YoY Change	237.71%	-0.09%	301.97%
Inventory	$499.3K	$857.8K	$233.5K
Prepaid Expenses
Receivables	$562.6K	$196.4K	$45.92K
Other Receivables	$83.10K	$25.56K	$143.3K
Total Short-Term Assets	$1.976M	$6.826M	$9.206M
YoY Change	-78.53%	64.1%	16.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.972M	$1.911M	$290.1K
YoY Change	579.58%	-20.7%	72.86%
Goodwill		$3.824M
YoY Change
Intangibles	$1.269K	$1.393K	$1.940K
YoY Change	-34.59%
Long-Term Investments	$86.99K	$84.35K	$94.15K
YoY Change	-7.6%	-9.42%
Other Assets	$15.56K	$15.52K	$18.80K
YoY Change	-17.23%
Total Long-Term Assets	$3.075M	$3.186M	$2.455M
YoY Change	25.26%	27.16%	1362.5%
TOTAL ASSETS
Total Short-Term Assets	$1.976M	$6.826M	$9.206M
Total Long-Term Assets	$3.075M	$3.186M	$2.455M
Total Assets	$5.051M	$10.01M	$11.66M
YoY Change	-56.68%	50.21%	44.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$398.5K	$508.0K	$406.2K
YoY Change	-1.89%	18.58%	938.25%
Accrued Expenses	$3.156M	$6.616M	$1.559M
YoY Change	102.44%	318.92%	179.19%
Deferred Revenue
YoY Change
Short-Term Debt	$86.99K	$84.35K	$94.15K
YoY Change	-7.6%	-81.79%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.322M	$9.287M	$4.452M
YoY Change	19.55%	178.12%	279.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$194.7K	$382.2K	$1.139M
YoY Change	-82.9%	-68.31%	3793.03%
Total Long-Term Liabilities	$194.7K	$382.2K	$1.139M
YoY Change	-82.9%	-68.31%	3793.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.322M	$9.287M	$4.452M
Total Long-Term Liabilities	$194.7K	$382.2K	$1.139M
Total Liabilities	$5.517M	$9.669M	$5.591M
YoY Change	-1.32%	112.74%	365.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.25M	-$14.73M	-$8.881M
YoY Change	71.72%
Common Stock	$250.00	$500.00	$500.00
YoY Change	-50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$466.2K	$342.1K	$6.069M
YoY Change
Total Liabilities & Shareholders Equity	$5.051M	$10.01M	$11.66M
YoY Change	-56.68%	50.21%	44.06%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$515.4K	-$4.374M	-$589.5K
YoY Change	-12.58%	2893.51%	215.34%
Depreciation, Depletion And Amortization	$102.7K	$25.70K	$74.20K
YoY Change	38.34%	132.79%	734.65%
Cash From Operating Activities	-$212.0K	-$641.1K	-$603.9K
YoY Change	-64.89%	-703.23%	-485.15%
INVESTING ACTIVITIES
Capital Expenditures	$104.2K	-$52.49K	-$1.340K
YoY Change	-7878.36%		6600.0%
Acquisitions
YoY Change
Other Investing Activities	-$3.812M	$446.4K	-$19.65K
YoY Change	19299.64%	428.57%	-137.94%
Cash From Investing Activities	-$3.916M	$393.9K	-$20.99K
YoY Change	18557.79%	366.43%	-140.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-863.7K	-2.305M	5.815M
YoY Change	-114.85%	1456.72%	-953.78%
NET CHANGE
Cash From Operating Activities	-212.0K	-641.1K	-603.9K
Cash From Investing Activities	-3.916M	393.9K	-20.99K
Cash From Financing Activities	-863.7K	-2.305M	5.815M
Net Change In Cash	-4.992M	-2.552M	5.190M
YoY Change	-196.19%	-6082.26%	-1198.4%
FREE CASH FLOW
Cash From Operating Activities	-$212.0K	-$641.1K	-$603.9K
Capital Expenditures	$104.2K	-$52.49K	-$1.340K
Free Cash Flow	-$316.3K	-$588.6K	-$602.5K
YoY Change	-47.51%	-653.83%	-484.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	AIXN	Government Grant GovernmentGrant		usd
CY2021Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Goodwill Goodwill		usd
CY2021Q4	AIXN	Accounts Payablerelated Party AccountsPayablerelatedParty		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000835662
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	AIXN	Prepayment For Acquisition PrepaymentForAcquisition		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	AIXN	Accrual Of Unpaid Investment In Subsidiary AccrualOfUnpaidInvestmentInSubsidiary		usd
	us-gaap	Transfer To Investments TransferToInvestments		usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2021Q4	AIXN	Inventory Allowance InventoryAllowance		usd
CY2021Q4	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent		usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent		usd
CY2022Q4	AIXN	Accounts Payablerelated Party AccountsPayablerelatedParty		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-17284
	dei	Entity Registrant Name EntityRegistrantName	AIXIN LIFE INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1085935
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Hongxing International Business Building 2, 14th FL
	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 69 Qingyun South Ave.
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jinjiang District
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chengdu City
	dei	Entity Address Country EntityAddressCountry	CN
	dei	City Area Code CityAreaCode	86
	dei	Local Phone Number LocalPhoneNumber	313-6732526
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value
	dei	Trading Symbol TradingSymbol	AIXN
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49999891	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5298503	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8556642	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	80303	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	44211	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	196376	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45923	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	162640	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	143281	usd
CY2022Q3	us-gaap	Supplies Supplies	137362	usd
CY2021Q4	us-gaap	Supplies Supplies	162969	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	857754	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	233454	usd
CY2022Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	92642	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	19055	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	6825580	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9205535	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1910691	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	290148	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1393	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1940	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15522	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18795	usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit	84347	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	94153	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1173616	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2049775	usd
CY2022Q3	us-gaap	Assets Assets	10011149	usd
CY2021Q4	us-gaap	Assets Assets	11660346	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	507993	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	406163	usd
CY2022Q3	AIXN	Accounts Payablerelated Party AccountsPayablerelatedParty	160911	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	153163	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	171408	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	55942	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	232637	usd
CY2022Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	5903738	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	752400	usd
CY2022Q3	AIXN	Government Grant GovernmentGrant	921473	usd
CY2022Q3	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	84347	usd
CY2021Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	94153	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	772632	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	848230	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	726650	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1947154	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9286849	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4452145	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	382152	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1138710	usd
CY2022Q3	us-gaap	Liabilities Liabilities	9669001	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5590855	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49999891	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49999891	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49999891	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49999891	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	500	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	500	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14365448	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14086793	usd
CY2022Q3	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2021Q4	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14734474	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8880613	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	558686	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	710823	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	342148	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10011149	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11660346	usd
CY2022Q3	us-gaap	Revenues Revenues	672786	usd
CY2021Q3	us-gaap	Revenues Revenues	812910	usd
	us-gaap	Revenues Revenues	1512351	usd
	us-gaap	Revenues Revenues	2363836	usd
CY2022Q3	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	215383	usd
CY2021Q3	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	130938	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	493905	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	291618	usd
CY2022Q3	AIXN	Hotel Operating Costs HotelOperatingCosts	404322	usd
CY2021Q3	AIXN	Hotel Operating Costs HotelOperatingCosts	320305	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	1334041	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	320305	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	193820	usd
CY2021Q3	us-gaap	Selling Expense SellingExpense	156587	usd
	us-gaap	Selling Expense SellingExpense	583438	usd
	us-gaap	Selling Expense SellingExpense	250468	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232642	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	187820	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	752113	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	607741	usd
CY2022Q3	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	67638	usd
CY2021Q3	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	17884	usd
	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	115495	usd
	AIXN	Reversal Of Provision For Bad Debts ReversalOfProvisionForBadDebts	17884	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1206690	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	906419	usd
	us-gaap	Operating Expenses OperatingExpenses	3557647	usd
	us-gaap	Operating Expenses OperatingExpenses	1766671	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-533904	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-93509	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2045296	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	597165	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1024	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	599	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3636	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3088	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	12134	usd
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	22067	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	41789	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	22228	usd
CY2022Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	29317	usd
CY2021Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1167	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	29577	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	8052	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3839929	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21499	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3807922	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17264	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4373833	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-72010	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5853218	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	614429	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5853861	usd
	us-gaap	Net Income Loss NetIncomeLoss	322283	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-139053	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-146104	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-322	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	74094	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	643	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	292146	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4373511	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6638	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-152137	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	83762	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4512564	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-139466	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6005998	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	406045	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.087
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.003
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.117
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.006
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49999891	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49999891	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49999891	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49999891	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31864	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-728269	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44948	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4761827	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4373511	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-139053	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	342148	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6892082	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	221702	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-32609	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7174060	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	246685	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	109733	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	7623363	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	92885	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	7623363	usd
CY2021Q3	AIXN	Acquisition Of Subsidiaries AcquisitionOfSubsidiaries	-7905941	usd
CY2021Q3	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	2448654	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-146104	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-146104	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6638	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2119495	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2119495	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5853861	usd
	us-gaap	Net Income Loss NetIncomeLoss	322283	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82921	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21910	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	115495	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17883	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	632496	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	217642	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1419	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	126720	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12806	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-13618	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-100801	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22975	usd
	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-13038	usd
	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	116795	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	192791	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18728	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	58507	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-748	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	143242	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-9444	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13136	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-187009	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	46672	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	525979	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	217642	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	232910	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-41986	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1412550	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	546069	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	446381	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	87448	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	52485	usd
	AIXN	Prepayment For Acquisition PrepaymentForAcquisition	4497972	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	393896	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4410524	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-1525860	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78415	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3222047	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4378854	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8600853	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-592814	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-677533	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-592814	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1525860	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7676689	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5378806	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3297835	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	72495	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	282319	usd
	AIXN	Accrual Of Unpaid Investment In Subsidiary AccrualOfUnpaidInvestmentInSubsidiary	3907139	usd
	us-gaap	Transfer To Investments TransferToInvestments	734290	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zyIrkSK2ph9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zsEyr14rzDml" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Reclassification</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	483346	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	213787	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	19641	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	672786	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	812910	usd
CY2022Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_840_eus-gaap--RevenueRecognitionDeferredRevenue_zf0dagH6zoi2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Unearned Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s unearned revenue primarily consists of advances received from customers for the rental of hotel rooms prior to the delivery of service. The room rental services are delivered (normally within one year) based upon contract terms and customer demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_znBvEbWMlqdk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentration of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB <span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uRMB_c20220930_zXkQKqmane15">500,000</span> ($<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uUSD_c20220930_zeQyYhuh9Zv5" title="Cash FDIC insured amount">72,500</span>) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three and nine months ended September 30, 2022, the Company had no customer that accounted for over 10% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zd8JRuB0qlVj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three months ended September 30, 2021, the Company had two major customers <span style="background-color: white">that </span> accounted for over 10% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_zt2nOtZMB0i8" style="display: none">SCHEDULE OF CONCENTRATION OF RISK BY RISK FACTORS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Customer</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total revenue for the three months ended<br/> September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F43_znXUMfQRbjib" style="width: 60%">A(1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_fKDEp_zUpMHofdkV62" style="width: 16%; text-align: right" title="Total revenue">146,140</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_fKDEp_zbc40lIi2Ema">18</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zbOPHELa9S55" style="text-align: right" title="Total revenue">299,076</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_fKg_____z4CPiKlDEgo6">37</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the nine months ended September 30, 2021, the Company had two major customers <span style="background-color: white">that </span> accounted for over 10% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Customer</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total revenue for the nine<br/> months ended<br/> September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F46_zkpLIb4JJfD7" style="width: 60%">A(1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_fKDEp_zaD42LmDjwt9" style="width: 16%; text-align: right" title="Total revenue">1,152,208</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_fKDEp_z9HMwYagYsIi">49</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zjQr2NnTGso3" style="text-align: right" title="Total revenue">590,688</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_fKg_____zseaBusW5tJd">25</span></td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three months ended September 30, 2022, the Company had one major supplier that accounted for over 10% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Supplier</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net purchases for the<br/> three months ended<br/> September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F49_zNJrajyaYAE8" style="width: 60%">C(2)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--PurchaseCost_pp0p0_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_fKDIp_zeZyCXhDA3I" style="width: 16%; text-align: right" title="Total purchases">88,948</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_fKDIp_zeJ5bzSFWThh" style="width: 16%; text-align: right">35</td><td style="width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the nine months ended September 30, 2022, the Company had one major supplier that accounted for over 10% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Supplier</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net purchases for the<br/> nine months ended<br/> September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4A_zOFFm0Ehi6jj" style="width: 60%">C(2)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--PurchaseCost_pp0p0_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_fKDIp_z7UvSF5T57Wh" style="width: 16%; text-align: right" title="Total purchases">152,629</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_fKDIp_zBe4gp9DUSN1" style="width: 16%; text-align: right">20</td><td style="width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the three months ended September 30, 2021, the Company had no supplier that accounted for over 10% of its total purchase. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the nine months ended September 30, 2021, the Company had one major supplier accounted for over 10% of its total purchase.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Supplier</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net purchases for the<br/> nine months ended<br/> September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of total purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">D</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--PurchaseCost_pp0p0_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_fKDIp_zqzQfYJ0cg9l" style="width: 16%; text-align: right" title="Total purchases">232,584</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_fKDIp_zqR4eNHf3vB4" style="width: 16%; text-align: right">69</td><td style="width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span id="xdx_F0A_zBCqkJxkLhqa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zlzsnw7pM4be" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represented advertising revenues from this customer during the three and nine months ended September 30, 2021. The Company also purchased inventory from this customer in the three and nine months ended September 30, 2021.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F07_zj72p0dY4z0a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zbomqnsnOEy" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company purchased inventory from this supplier, Runcansheng, in the three and nine months ended September 30, 2022. The Company acquired all of the outstanding equity of Runcangsheng on September 30, 2022 (see Note 17).</span></td></tr> </table> <p id="xdx_8A2_z4d5WMe77Rel" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	72500	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1206690	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	906419	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-533904	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-93509	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1512351	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2363836	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3557647	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1766671	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2045296	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	597165	usd
CY2022Q3	us-gaap	Assets Assets	10011149	usd
CY2021Q4	us-gaap	Assets Assets	11660346	usd
CY2022Q3	us-gaap	Deposit Assets DepositAssets	14928	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	68433	usd
CY2022Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	122150	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	50221	usd
CY2022Q3	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10584	usd
CY2021Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	13839	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	14978	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	10788	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	162640	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	143281	usd
CY2022Q3	us-gaap	Supplies Supplies	137362	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	751071	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	829085	usd
CY2021Q4	us-gaap	Supplies Supplies	162969	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	152140	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4600	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	183148	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6201	usd
CY2022Q3	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	454165	usd
CY2021Q4	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	122966	usd
CY2022Q3	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	83342	usd
CY2021Q4	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	104287	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	877395	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	233454	usd
CY2022Q3	AIXN	Inventory Allowance InventoryAllowance	19641	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	857754	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	233454	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2739776	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	460923	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1910691	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	290148	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25111	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10608	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	81036	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21478	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8479	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7896	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7086	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5956	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1393	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1940	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	591	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	432	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1885	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	432	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	55942	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	232637	usd
CY2022Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	258094	usd
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	327735	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	264613	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	179183	usd
CY2022Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	11625	usd
CY2021Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	29000	usd
CY2022Q3	us-gaap	Construction Payable Current ConstructionPayableCurrent	1463969	usd
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	111807	usd
CY2022Q3	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	20051	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	206427	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	50840	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11668	usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	12239	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	44998	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	41596	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3622293	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5903738	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	752400	usd
CY2022Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	84347	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	94153	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P2Y
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	207049	usd
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1389731
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2021-03-31
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1173616	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2049775	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	772632	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	848230	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	382152	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1138710	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1154784	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1986940	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	183051	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	161389	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	632496	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	217642	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	525979	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	217642	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M24D
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M1D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	215864	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	782260	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	123488	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	51579	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21751	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1194942	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40158	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1154784	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	772632	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	382152	usd
CY2022Q3	AIXN	Accounts Payablerelated Party AccountsPayablerelatedParty	160911	usd
CY2022Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	92642	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	19055	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	726650	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1947154	usd
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	5000
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	757	usd
CY2014Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-05-28
CY2022Q3	AIXN	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	6056	usd
CY2020Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49999891	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49999891	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49999891	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49999891	shares
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	278655	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	765552	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
	AIXN	Net Income Transfer Percentage NetIncomeTransferPercentage	0.10	pure
	AIXN	Capital Reserve Percentage CapitalReservePercentage	0.50	pure
CY2022Q3	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
CY2021Q3	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_800_eus-gaap--LossContingencyDisclosures_zxs3WbY0dH5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>16. <span id="xdx_82A_z3l7pifaVSG3">OPERATING CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Litigation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $<span id="xdx_905_eus-gaap--LongTermPurchaseCommitmentAmount_uUSD_c20201201__20201231__us-gaap--GuaranteeObligationsByNatureAxis__us-gaap--IndemnificationGuaranteeMember_z01ReVyboHZ8" title="Purchase commitment amount">392,305</span> (RMB <span id="xdx_909_eus-gaap--LongTermPurchaseCommitmentAmount_uRMB_c20201201__20201231__us-gaap--GuaranteeObligationsByNatureAxis__us-gaap--IndemnificationGuaranteeMember_zRTSTMhHU901" title="Purchase commitment amount">2,500,000</span>) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $<span id="xdx_909_eus-gaap--LitigationSettlementExpense_uUSD_c20201201__20201231_zHrdYWrEDbJd" title="Litigation settlement expense">392,305</span> (RMB <span id="xdx_90E_eus-gaap--LitigationSettlementExpense_uRMB_c20201201__20201231_zJdnecNOJPA7" title="Litigation settlement expense">2,500,000</span>) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	392305	usd
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2500000
CY2022Q3	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	4301293	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	446381	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Receivable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivable	144813	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Receivable Related Party BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsReceivableRelatedParty	133011	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance To Suppliers BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceToSuppliers	3455	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	127909	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	469594	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1677272	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1406	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Operating Lease Right Use Of Assetst BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseRightUseOfAssetst	1990	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1314995	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	3005831	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	89801	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Related Party BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableRelatedParty	-160911	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Advance From Customer BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAdvanceFromCustomer	-4790	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Government Grant BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesGovernmentGrant	-921473	usd
CY2022Q3	AIXN	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Taxes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesTaxesPayable	-21156	usd
CY2022Q3	AIXN	Operating Lease Liabilities OperatingLeaseLiabilities	-15182	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	2528308	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	477523	usd
CY2022Q3	us-gaap	Goodwill Goodwill	3823770	usd

Files In Submission

Name	View Source	Status
0001493152-22-032179-index-headers.html	Edgar Link	pending
0001493152-22-032179-index.html	Edgar Link	pending
0001493152-22-032179.txt	Edgar Link	pending
0001493152-22-032179-xbrl.zip	Edgar Link	pending
aixn-20220930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
aixn-20220930_def.xml	Edgar Link	unprocessable
aixn-20220930_lab.xml	Edgar Link	unprocessable
aixn-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aixn-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIXN
AiXin Life International, Inc. Stock $aixn

2022 Q4 Form 10-Q Financial Statement

#000149315222032179 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN AiXin Life International, Inc. Stock $aixn

2022 Q4 Form 10-Q Financial Statement

#000149315222032179 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN
AiXin Life International, Inc. Stock $aixn